Latka logo

Instavast vs PCL Health: Revenue, Funding & Team Size Compared

Instavast generates $360K in revenue; PCL Health generates $354.5K. Instavast and PCL Health are close to the same size by revenue. The table below compares Instavast and PCL Health on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Instavast vs PCL Health compared on revenue, funding, valuation, customers and team size
CompanyInstavast logoInstavastThis companyPCL Health logoPCL Health
Revenue$360K$354.5K
ValuationNot disclosed$2.8M
Funding raisedNot disclosed$535.8K
Team size1011
Founded20172018
HQUnited StatesLondon, United Kingdom

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Instavast logo

Instavast at a glance

Instavast generates $360K in revenue with 10 employees, headquartered in United States.

Revenue
$360K
Team size
10
Founded
2017

web-app for Instagram automation

PCL Health logo

PCL Health at a glance

PCL Health generates $354.5K in revenue with 11 employees, headquartered in London, United Kingdom.

Revenue
$354.5K
Valuation
$2.8M
Funding
$535.8K
Team size
11
Founded
2018

B2B SaaS bringing Remote Health Monitoring to next level with AI-driven analytics and integrated IoTs

Other Instavast alternatives

Instavast competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Instavast vs PCL Health: frequently asked questions

Is Instavast or PCL Health bigger?

Instavast is the bigger company by revenue, at $360K against $354.5K for PCL Health.

How much revenue does Instavast make?

Instavast generates $360K in annual revenue with a team of 10.

How much revenue does PCL Health make?

PCL Health generates $354.5K in annual revenue with a team of 11.

How much funding has PCL Health raised?

PCL Health has raised $535.8K in total funding since it was founded in 2018.